Acadia Pharmaceuticals (DR6.F) Q4 2024 Earnings

6NovConfirmed
Q1 2024
Q2 2024
Q3 2024
Q4 2024
0.05
0.12
0.19
0.27

Details

Expected EPS
0.1267201584
Actual EPS
0.18354600000000001
Surprise EPS
0.06
Surprise Percent
+44.84%

Description

Acadia Pharmaceuticals (DR6.F) has reported earnings of 0.18354600000000001 per share for Q4 2024.

0 Comments

Share your thoughts